Chagas disease in solid organ and heart transplantation

Current Opinion in Infectious Diseases

Volumn 27, Issue 5, 2014, Pages 418-424

  Kransdorf, Evan P ^a,b   Zakowski, Phillip C ^c   Kobashigawa, Jon A ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b MAYO CLINIC   (United States)

^c Tower ID Medical Associates ^*  (United States)

Author keywords

Chagas cardiomyopathy; Chagas disease; donor selection; heart transplantation; organ donor Trypanosoma cruzi

Indexed keywords

CHAGAS DISEASE; DISEASE TRANSMISSION; DONOR SELECTION; GRAFT RECIPIENT; HEART TRANSPLANTATION; HUMAN; INFECTION RISK; ORGAN DONOR; ORGAN TRANSPLANTATION; PARASITE TRANSMISSION; PATIENT MONITORING; REVIEW; SOLID ORGAN TRANSPLANTATION; TRYPANOSOMA CRUZI; ADVERSE EFFECTS; DONOR; HEALTH SURVEY; ISOLATION AND PURIFICATION; LIVER TRANSPLANTATION; PREVALENCE; PUBLIC HEALTH; RISK ASSESSMENT; RISK FACTOR; UNITED STATES;

CHAGAS DISEASE; HEART TRANSPLANTATION; HUMANS; LIVER TRANSPLANTATION; POPULATION SURVEILLANCE; PREVALENCE; PUBLIC HEALTH; RISK ASSESSMENT; RISK FACTORS; TISSUE DONORS; TRYPANOSOMA CRUZI; UNITED STATES;

EID: 84906940485     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0000000000000088     Document Type: Review

References (51)

1. Rassi A Jr, Rassi A, Marin-Neto JA. Chagas disease. Lancet 2010; 375:1388-1402.
2. Moncayo A, Silveira AC. Current epidemiological trends for Chagas disease in Latin America and future challenges in epidemiology, surveillance and health policy. Mem Inst Oswaldo Cruz 2009; 104 (Suppl 1):17-30.
3. Chagas' Disease Argentine Collaborative Transplant Consortium. Casadei D., Chagas' disease and solid organ transplantation. Transplant Proc 2010; 42: 3354-3359.
4. Huprikar S, Bosserman E, Patel G, et al. Donor-derived Trypanosoma cruzi infection in solid organ recipients in the United States, 2001-2011. Am J Transplant 2013; 13:2418-2425.
5. Organizacion Nacional de Trasplantes, World Health Organization. Organ donation and transplantation activities 2010. Available at: https://reports. ont.es/ccaaan.aspx. [Accessed 1 May 2014]
6. Schmunis GA, Yadon ZE. Chagas disease: a Latin American health problem becoming a world health problem. Acta Tropica 2010; 115:14-21.
7. Jackson Y, Dang T, Schnetzler B, et al. Trypanosoma cruzi fatal reactivation in a heart transplant recipient in Switzerland. J Heart Lung Transplant 2011; 30:484-485.
8. Kransdorf EP, Czer LSC, Luthringer DJ, et al. Heart transplantation for Chagas cardiomyopathy in the United States. Am J Transplant 2013; 13: 3262-3268.
9. Bertolino ND, Villafanha DF, Cardinalli-Neto A, et al. Prognostic impact of Chagas' disease in patients awaiting heart transplantation. J Heart Lung Transplant 2010; 29:449-453.
10. Ayub-Ferreira SM, Mangini S, Issa VS, et al. Mode of death on Chagas heart disease: comparison with other etiologies. A subanalysis of the REMADHE Prospective Trial. PLoS Negl Trop Dis 2013; 7:e2176.
11. Padilla B, Peixoto J. Latin American immigration to Southern Europe 2014. Available at: http://www.migrationpolicy.org/article/latin-american- immigration-southern-europe. [Accessed 1 May 2014]
12. Bern C, Montgomery SP. An estimate of the burden of Chagas disease in the United States. Clin Infect Dis 2009; 49:e52-e54.
13. Montgomery SP, Starr MC, Cantey PT, et al. Neglected parasitic infections in the United States: Chagas disease. Am J Trop Med Hyg 2014; 90:814-818.
14. Custer B, Agapova M, Bruhn R, et al. Epidemiologic and laboratory findings from 3 years of testing United States blood donors for Trypanosoma cruzi. Transfusion 2012; 52:1901-1911.
15. Pé rez de Ayala A, Pé rez-Molina J-A, Norman F, Ló pez-Vé lez R. Chagasic cardiomyopathy in immigrants from Latin America to Spain. Emerg Infect Dis 2009; 15:607-608.
16. Seguro LF, Braga FGM, Avila MS, et al. Profile of heart transplant recipients in a Brazilian center: comparison with international registry. J Heart Lung Transplant 2014; 33:S264.
17. Kapelusznik L, Varela D, Montgomery SP, et al. Chagas disease in Latin American immigrants with dilated cardiomyopathy in New York City. Clin Infect Dis 2013; 57:e7-e7.
18. Traina M, Sanchez D, Hernandez S, et al. Abstract 18171: Chagasic cardiomyopathy is associated with increased morbidity and mortality compared to nonischemic cardiomyopathy among Latin American immigrants living in Los Angeles. American Heart Association Scientific Sessions; 2013.
19. WHO Expert Committee. Control of Chagas disease. World Health Organization Technical Report Series, Geneva 2002; 905:1-109.
20. Laranja FS, Dias E, Nobrega G, Miranda A. Chagas' disease: a clinical, epidemiologic, and pathologic study. Circulation 1956; 14:1035-1060.
21. Sabino EC, Ribeiro AL, Salemi VMC, et al. Ten-year incidence of Chagas cardiomyopathy among asymptomatic Trypanosoma cruzi-seropositive former blood donors. Circulation 2013; 127:1105-1115.
22. Moreira OC, Raḿrez JD, Velázquez E, et al. Towards the establishment of a consensus real-time qPCR to monitor Trypanosoma cruzi parasitemia in patients with chronic Chagas disease cardiomyopathy: a substudy from the BENEFIT trial. Acta Tropica 2013; 125:23-31.
23. Morillo CA. Infection with Trypanosoma cruzi and progression to cardiomyopathy: what is the evidence and is the tide finally turning Circulation 2013; 127:1095-1097.
24. Borges DC, Araú jo NM, Cardoso CR, Lazo Chica JE. Different parasite inocula determine themodulation of the immune response and outcome of experimental Trypanosoma cruzi infection. Immunology 2013; 138:145-156.
25. Kun H, Moore A, Mascola L, et al. Transmission of Trypanosoma cruzi by heart transplantation. Clin Infect Dis 2009; 48:1534-1540.
26. Chin-Hong PV, Schwartz BS, Bern C, et al. Screening and treatment of Chagas disease in organ transplant recipients in the United States: recommendations from the Chagas in transplant working group. Am J Transplant 2011; 11:672-680.
27. McCormack L, Quiñó nez E, Goldaracena N, et al. Liver transplantation using Chagas-infected donors in uninfected recipients: a single-center experience without prophylactic therapy. Am J Transplant 2012; 12:2832-2837.
28. Cicora F, Escurra V, Silguero S, et al. Use of kidneys from Trypanosoma cruziinfected donors in naive transplant recipients without prophylactic therapy. Transplantation 2014; 97:e3-e4.
29. de Andrade JP, Marin-Neto JA, de Paola AAV, et al. Latin American guidelines for the diagnosis and treatment of Chagas' heart disease: executive summary. Arq Bras Cardiol 2011; 96:434-442.
30. Schwartz BS, Paster M, Ison MG, Chin-Hong PV. Organ donor screening practices for Trypanosoma cruzi infection among US organ procurement organizations. Am J Transplant 2011; 11:848-851.
31. Wallace JA, Miller L, Beavis A, Baptista CAC. Chagas disease: a proposal for testing policy for solid-organ transplant in the United States. Prog Transplant 2013; 23:272-277.
32. United States Census Bureau. 2010 Census Data 2010. Available at: http://www.census.gov/2010census/data [Accessed 1 May 2014].
33. Nowicki MJ, Chinchilla C, Corado L, et al. Prevalence of antibodies to Trypanosoma cruzi among solid organ donors in Southern California: a population at risk. Transplantation 2006; 81:477-479.
34. Mart́n-Dá vila P, Fortún J, Ló pez-Vé lez R, et al. Transmission of tropical and geographically restricted infections during solid-organ transplantation. Clin Microbiol Rev 2008; 21:60-96.
35. Organizacion Nacional de Trasplantes. Documento de Consenso de Donacion e Infeccion 2004. Available at: http://www.ont.es/infesp/Paginas/ DocumentosdeConsenso. aspx [Accessed 1 May 2014].
36. Kirchhoff LV. American trypanosomiasis (Chagas' disease)-a tropical disease now in the United States. N Engl J Med 1993; 329:639-644.
37. Godoy HL, Guerra CM, Viegas RF, et al. Almeida DR: infections in heart transplant recipients in Brazil: the challenge of Chagas' disease. J Heart Lung Transplant 2010; 29:286-290.
38. de Souza MM, Franco M, Almeida DR, et al. Comparative histopathology of endomyocardial biopsies in chagasic and nonchagasic heart transplant recipients. J Heart Lung Transplant 2001; 20:534-543.
39. Hall CS, Fields K. Cutaneous presentation of Chagas' disease reactivation in a heart-transplant patient in Utah. J Am Acad Dermatol 2008; 58:529-530.
40. Bocchi EA, Fiorelli A. First guideline group for heart transplantation of the Brazilian Society of Cardiology: the Brazilian experience with heart transplantation: a multicenter report. J Heart Lung Transplant 2001; 20:637-645.
41. Fiorelli AI, Santos RHB, Oliveira JL, et al. Heart transplantation in 107 cases of Chagas' disease. Transplant Proc 2011; 43:220-224.
42. Kransdorf EP, Fishbein MC, Czer L, et al. Pathology of chronic Chagas cardiomyopathy in the United States: a detailed review of 12 cardiectomy cases. Mod Pathol 2014; 27:91A.
43. Benvenuti LA, Roggé rio A, Nishiya AS, et al. Trypanosoma cruzi persistence in the native heart is associated with high-grade myocarditis, but not with Chagas' disease reactivation after heart transplantation. J Heart Lung Transplant 2014. [Epub ahead of print]
44. Bern C. Antitrypanosomal therapy for chronic Chagas' disease. N Engl J Med 2011; 364:2527-2534.
45. Maldonado C, Albano S, Vettorazzi L, et al. Using polymerase chain reaction in early diagnosis of re-activated Trypanosoma cruzi infection after heart transplantation. J Heart Lung Transplant 2004; 23:1345-1348.
46. Diez M, Favaloro L, Bertolotti A, et al. Usefulness of PCR strategies for early diagnosis of Chagas' disease reactivation and treatment follow-up in heart transplantation. Am J Transplant 2007; 7:1633-1640.
47. Qvarnstrom Y, Schijman AG, Veron V, et al. Sensitive and specific detection of Trypanosoma cruzi DNA in clinical specimens using a multitarget real-time PCR approach. PLoS Negl Trop Dis 2012; 6:e1689.
48. Campos SV, Strabelli TMV, Amato Neto V, et al. Risk factors for Chagas' disease reactivation after heart transplantation. J Heart Lung Transplant 2008; 27:597-602.
49. Olivieri BP, Molina JT, de Castro SL, et al. A comparative study of posaconazole and benznidazole in the prevention of heart damage and promotion of trypanocidal immune response in a murine model of Chagas disease. Int J Antimicrob Agents 2010; 36:79-83.
50. Grosso NL, Alarcon ML, Bua J, et al. Combined treatment with benznidazole and allopurinol in mice infected with a virulent Trypanosoma cruzi isolate from Nicaragua. Parasitology 2013; 140:1225-1233.
51. Molina I,Gómez i Prat J, Salvador F, et al. Randomized trial of posaconazole and benznidazoleforchronicChagas'disease.N Engl J Med2014;370:1899-1908.